Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.
https://drugscience.org.uk/
episode 13: 13. The Vape Debate with Gerry Stimson
The emergence of vaping and e-cigarettes is a relatively new and novel form of harm reduction. The UK has taken a scientific approach to the regulation of vaporisers and has been rewarded with great reductions of new and existing tobacco smokers. However, internationally vaporisers have been met with great distain and in some cases prohibition. In the past few years, we have seen a deliberate attempt to mislead the public over the harms of vaping nicotine and other cigarette substitute products.
Professor Gerry Stimson is a sociologist who has been promoting a harm reduction approach to public health since 1987. This began with harm reduction messaging for drug use to minimise HIV infection rates. This later expanded to other harm reduction tactics such as alcohol and tobacco control. In 2004, Gerry was appointed Emeritus Professor at Imperial College London. In 2017, he was appointed Honorary Professor at the London School of Hygiene and Tropical Medicine.
Together, Professor Nutt and Professor Stimson will unravel facts from fiction and answer:
Why are UK regulations so effective?
Should we fear ‘big tobacco’ involvement with vaporisers?
Abstinence vs harm reduction
Why is vaping stigmatised?
How does vaping change user’s relationship with nicotine?
Should we ban flavours?
Global State of Tobacco Harm Reduction
Tobacco harm reduction and the right to health
GSHR twitter
Needle exchange
What is harm reduction?
Snus
Nicotine replacement therapy
Nicotine
Drug Harm analysis
Nicotine MCDA
Public Health England e-cigarette report
US flavour ban
WHO stance on vaping
COVID and vaping
Vaping by Clive Bates
Become a Drug Science Community Member: https://www.donate.drugscience.org.uk/
Twitter: @ProfDavidNutt @Drug_Science
A Fascinate Productions podcast for Drug Science
★ Support this podcast ★